#USA #Clinical Trials #Ryght AI #Laguna Beach #RyghtSites

RyghtSites.com: A Breakthrough in Clinical Trial Site Selection

In a significant advancement for the clinical research community, Ryght AI has officially launched RyghtSites.com, the world’s first free AI-powered clinical trial site search engine. Designed to support drug developers and Contract Research Organizations (CROs), this tool promises to streamline the process of identifying and selecting clinical research sites across the globe.

Addressing the Industry Challenge

The clinical trial landscape is notorious for its inefficiencies, with an alarming 80% of trials lacking proper enrollment timelines. The root of this issue lies in outdated methodologies that rely heavily on manual processes and expensive data contracts. Traditionally, the site selection process can take an agonizing three to six months, resulting in substantial delays and substantial financial losses in drug development.

Ryght AI aims to turn this situation around. Through RyghtSites.com, users gain access to a comprehensive database of over 60,000 AI-powered Site Twins, summarizing more than 100,000 research sites worldwide in 192 countries.

Key Features of RyghtSites.com

RyghtSites.com boasts several compelling features that enable users to expedite site selection:

• - Global Database Search: Effortlessly browse through 100,000 clinical research locations
• - Filtering by Indication: Sort sites based on disease categories, biomarkers, or geographic regions
• - Support for All Phases: Compatible with Phase 1 through 4 clinical trials
• - Agentic Ranking: Automatically rank sites based on feasibility and compatibility
• - Downloadable Data Access: Retrieve data and lists in CSV format for easy sharing and analysis

This innovative tool aims to minimize the manual burdens typically associated with site identification, thus reducing wasted time and finances. By providing not just lists of sites but also their trial histories, RyghtSites.com empowers researchers with the relevant insights needed for effective decision-making.

Proven Efficiency

In a notable case, a leading global CRO utilized Ryght’s platforms to condense a typical six-month oncology site selection project into just 26 days. Not only did they achieve their goals, but they surpassed recruitment expectations by a whopping 330%. Such outcomes highlight how AI-driven solutions can enhance operational efficiency and effectiveness in clinical trial planning.

The Vision Behind Ryght AI

Simon Arkell, CEO and Co-Founder of Ryght AI, stated, “Traditional site selection methods are costing the industry valuable time and resources. RyghtSites.com is our answer to providing sponsors and CROs with a smarter starting point, leveraging AI infrastructure for accelerated site selection.” With this robust platform, Ryght AI is shifting the paradigm for clinical trials, ensuring researchers can focus more on innovation rather than logistical hurdles.

For pharmaceutical firms and CROs eager to simplify their trial preparations, RyghtSites.com is a game-changer. Users can begin exploring this novel site-search technology free of charge today at the website. Discovering the most suitable clinical research sites has never been easier or more efficient.

About Ryght AI

Founded in 2024, Ryght AI is pioneering the integration of AI in clinical trial site operations. By creating a dynamic ecosystem of over 100,000 trial sites, the company enhances the overall efficiency of drug development and expands patient access to new therapies. With backing from high-profile investors including Accenture Ventures, Ryght AI is poised to innovation in the clinical research landscape. Learn more about their transformative work at www.ryght.ai.